A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

Trial Profile

A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

Recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs Benzoyl peroxide (Primary)
  • Indications Rosacea
  • Focus Registrational; Therapeutic Use
  • Sponsors Sol-Gel Technologies
  • Most Recent Events

    • 18 Jun 2018 According to a Sol-Gel Technologies media release, the company expects to report top-line data from this trial in 2019.
    • 18 Jun 2018 According to a Sol-Gel Technologies media release, status changed from not yet recruiting to recruiting.
    • 26 Mar 2018 According to the Sol-Gel Technologies media release, this trial is expected to start in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top